Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Assessment of data transformations for model-based clustering of RNA-Seq data
Janelle R. NoeI-MacDonnell et al.
PLOS ONE (2018)
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
Sang Cheul Oh et al.
NATURE COMMUNICATIONS (2018)
Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay
Michaela Tsai et al.
JAMA ONCOLOGY (2018)
A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma
Yanding Zhao et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Advances in ovarian cancer therapy
Alexander J. Cortez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer
Yue Wang et al.
SCIENTIFIC REPORTS (2017)
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E. Gershenwald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment
Frederick S. Varn et al.
CANCER RESEARCH (2017)
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
Milena P. Mak et al.
CLINICAL CANCER RESEARCH (2016)
Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials
Kasper Toustrup et al.
ACTA ONCOLOGICA (2016)
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles
Frederick S. Varn et al.
NATURE COMMUNICATIONS (2016)
Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcome
Tracy A. O'Mara et al.
SCIENTIFIC REPORTS (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Identification of Subtype-Specific Prognostic Genes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients Using an Embedded Feature Selection Algorithm
Suyan Tian
PLOS ONE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
Suk-Joon Chang et al.
GYNECOLOGIC ONCOLOGY (2013)
Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures
Scott E. Kern
CANCER RESEARCH (2012)
Genes with Bimodal Expression Are Robust Diagnostic Targets that Define Distinct Subtypes of Epithelial Ovarian Cancer with Different Overall Survival
Dawn N. Kernagis et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
A gene expression signature for high-risk multiple myeloma
R. Kuiper et al.
LEUKEMIA (2012)
Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
Stefan Bentink et al.
PLOS ONE (2012)
A seven-gene prognostic model for platinum-treated ovarian carcinomas
R. Sabatier et al.
BRITISH JOURNAL OF CANCER (2011)
Making sense of cancer genomic data
Lynda Chin et al.
GENES & DEVELOPMENT (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Jozsef Timar et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?
Jyothi Subramanian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Prediction of breast cancer prognosis by gene expression profile of TP53 status
Shin Takahashi et al.
CANCER SCIENCE (2008)
Inferring activity changes of transcription factors by binding association with sorted expression profiles
Chao Cheng et al.
BMC BIOINFORMATICS (2007)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
